Search All News
The funding enables the Irving Institute for Clinical and Translational Research to maintain more than 70 services and programs to help Columbia researchers
The TRx resource at Columbia University's Irving Institute offers guidance and connections for researchers wanting commercialization support.
The Irving Institute Community Engagement Core Resource (CECR) was given the Match Maestro award from ResearchMatch in 2018 and supported this study.
Source:CUIMC NewsroomDecember 10, 2020
New technology, supported through Irving Institute grant, could be used to treat dozens of diseases.
- August 17, 2020
Fourteen teams of Columbia faculty have been awarded a Columbia Life Science Accelerator grant to support cutting-edge translational research
- August 11, 2020
The CaMPR pilot award program focuses on the innovative assembly of new teams to gather preliminary data to address unresolved clinical, translational and public health problems
- May 26, 2020
In partnership with the Herbert Irving Comprehensive Cancer Center and Biomedical Engineering
- August 1, 2019
Irving Institute Announces 2018-2019 Translational Therapeutics Accelerator Pilot Awardees
- November 7, 2018
Translational Therapeutics (TRx) Accelerator hosted the first Translational Therapeutics Symposium at Columbia University.
- August 1, 2018
Irving Institute Announces 2017-2018 Translational Therapeutics Accelerator Pilot Awardees